Literature DB >> 31656020

Review: Ewing Sarcoma Predisposition.

Pablo Gargallo1, Yania Yáñez2, Antonio Juan3, Vanessa Segura2, Julia Balaguer3, Bárbara Torres3, Silves Oltra4,5, Victoria Castel3, Adela Cañete3.   

Abstract

Ewing sarcoma is a rare tumor developed in bone and soft tissues of children and teenagers. This entity is biologically led by a chromosomal translocation, typically including EWS and FLI1 genes. Little is known about Ewing sarcoma predisposition, although the role of environmental factors, ethnicity and certain polymorphisms on Ewing sarcoma susceptibility has been studied during the last few years. Its prevalence among cancer predisposition syndromes has also been thoroughly examined. This review summarizes the available evidence on predisposing factors involved in Ewing sarcoma susceptibility. On the basis of these data, an integrated approach of the most influential factors on Ewing sarcoma predisposition is proposed.

Entities:  

Keywords:  Cancer predisposition; Ewing sarcoma; Genetic susceptibility; Polymorphism

Mesh:

Substances:

Year:  2019        PMID: 31656020     DOI: 10.1007/s12253-019-00765-3

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  93 in total

1.  Epidemiology of bone cancer in children.

Authors:  A G Glass; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1970-01       Impact factor: 13.506

Review 2.  Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets.

Authors:  Stephen L Lessnick; Marc Ladanyi
Journal:  Annu Rev Pathol       Date:  2011-09-19       Impact factor: 23.472

3.  Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.

Authors:  Iori Takigami; Takatoshi Ohno; Yukio Kitade; Akira Hara; Akihito Nagano; Gou Kawai; Mitsuru Saitou; Aya Matsuhashi; Kazunari Yamada; Katsuji Shimizu
Journal:  Int J Cancer       Date:  2011-01-01       Impact factor: 7.396

4.  Ewing's sarcoma in Negroes.

Authors:  G Linden; J E Dunn
Journal:  Lancet       Date:  1970-05-30       Impact factor: 79.321

5.  Rarity of Ewing's tumour in Negroes.

Authors:  R D Jensen; R M Drake
Journal:  Lancet       Date:  1970-04-11       Impact factor: 79.321

6.  Rarity of Ewing's sarcoma among U.S. Negro children.

Authors:  J F Fraumeni; A G Glass
Journal:  Lancet       Date:  1970-02-14       Impact factor: 79.321

7.  Rarity of Ewing's sarcoma in China.

Authors:  F P Li; J T Tu; F S Liu; E L Shiang
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

8.  A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature.

Authors:  Jeffrey D Hancock; Stephen L Lessnick
Journal:  Cell Cycle       Date:  2007-10-30       Impact factor: 4.534

9.  Childhood cancer incidence and survival in Japan and England: A population-based study (1993-2010).

Authors:  Kayo Nakata; Yuri Ito; Winnie Magadi; Audrey Bonaventure; Charles A Stiller; Kota Katanoda; Tomohiro Matsuda; Isao Miyashiro; Kathy Pritchard-Jones; Bernard Rachet
Journal:  Cancer Sci       Date:  2017-12-26       Impact factor: 6.716

10.  Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma.

Authors:  S Sankar; R Bell; B Stephens; R Zhuo; S Sharma; D J Bearss; S L Lessnick
Journal:  Oncogene       Date:  2012-11-26       Impact factor: 9.867

View more
  1 in total

1.  A Visualized Dynamic Prediction Model for Lymphatic Metastasis in Ewing's Sarcoma for Smart Medical Services.

Authors:  Wenle Li; Chan Xu; Zhaohui Hu; Shengtao Dong; Haosheng Wang; Qiang Liu; Zhi-Ri Tang; Wanying Li; Bing Wang; Zhi Lei; Chengliang Yin
Journal:  Front Public Health       Date:  2022-05-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.